Jan Bednarsch1, Zoltan Czigany1, Daniel Heise1, Katharina Joechle1, Tom Luedde2, Lara Heij1,3, Philipp Bruners4, Tom Florian Ulmer1, Ulf Peter Neumann1,5, Sven Arke Lang6. 1. Department of Surgery and Transplantation, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074, Aachen, Germany. 2. Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany. 3. Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany. 4. Department of Radiology, University Hospital RWTH Aachen, Aachen, Germany. 5. Department of Surgery, Maastricht University Medical Centre (MUMC), Maastricht, Netherlands. 6. Department of Surgery and Transplantation, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074, Aachen, Germany. svlang@ukaachen.de.
Abstract
PURPOSE: No consensus exists regarding the most appropriate staging system to predict overall survival (OS) for hepatocellular carcinoma (HCC) in surgical candidates. Thus, we aimed to determine the prognostic ability of eight different staging systems in a European cohort of patients undergoing liver resection for HCC. METHODS: Patients resected for HCC between 2010 and 2019 at our institution were analyzed with Kaplan-Meier and Cox regression analyses. Likelihood ratio (LR) χ2 (homogeneity), linear trend (LT) χ2 (discriminatory ability), and Akaike Information Criterion (AIC, explanatory ability) were used to determine the staging system with the best overall prognostic performance. RESULTS: Liver resection for HCC was performed in 160 patients. Median OS was 39 months (95% confidence interval (CI): 32-46 months) and median RFS was 26 months (95% CI: 16-34 months). All staging systems (BCLC, HKLC, Okuda, CLIP, ITA.LI.CA staging and score, MESH, and GRETCH) showed significant discriminatory ability regarding OS, with ITA.LI.CA score (LR χ2 30.08, LT χ2 13.90, AIC 455.27) and CLIP (LR χ2 28.65, LT χ2 18.95, AIC 460.07) being the best performing staging systems. CONCLUSIONS: ITA.LI.CA and CLIP are the most suitable staging system to predict OS in European HCC patients scheduled for curative-intent surgery.
PURPOSE: No consensus exists regarding the most appropriate staging system to predict overall survival (OS) for hepatocellular carcinoma (HCC) in surgical candidates. Thus, we aimed to determine the prognostic ability of eight different staging systems in a European cohort of patients undergoing liver resection for HCC. METHODS:Patients resected for HCC between 2010 and 2019 at our institution were analyzed with Kaplan-Meier and Cox regression analyses. Likelihood ratio (LR) χ2 (homogeneity), linear trend (LT) χ2 (discriminatory ability), and Akaike Information Criterion (AIC, explanatory ability) were used to determine the staging system with the best overall prognostic performance. RESULTS: Liver resection for HCC was performed in 160 patients. Median OS was 39 months (95% confidence interval (CI): 32-46 months) and median RFS was 26 months (95% CI: 16-34 months). All staging systems (BCLC, HKLC, Okuda, CLIP, ITA.LI.CA staging and score, MESH, and GRETCH) showed significant discriminatory ability regarding OS, with ITA.LI.CA score (LR χ2 30.08, LT χ2 13.90, AIC 455.27) and CLIP (LR χ2 28.65, LT χ2 18.95, AIC 460.07) being the best performing staging systems. CONCLUSIONS: ITA.LI.CA and CLIP are the most suitable staging system to predict OS in European HCCpatients scheduled for curative-intent surgery.
Entities:
Keywords:
CLIP; HCC; ITA.LI.CA; Liver resection; Staging system
Authors: Martin Stockmann; Johan F Lock; Björn Riecke; Karsten Heyne; Peter Martus; Michael Fricke; Sina Lehmann; Stefan M Niehues; Michael Schwabe; Arne-Jörn Lemke; Peter Neuhaus Journal: Ann Surg Date: 2009-07 Impact factor: 12.969
Authors: Nuh N Rahbari; Arianeb Mehrabi; Nathan M Mollberg; Sascha A Müller; Moritz Koch; Markus W Büchler; Jürgen Weitz Journal: Ann Surg Date: 2011-03 Impact factor: 12.969
Authors: V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari Journal: N Engl J Med Date: 1996-03-14 Impact factor: 176.079
Authors: Jan Bednarsch; Xiuxiang Tan; Zoltan Czigany; Georg Wiltberger; Roman David Buelow; Peter Boor; Sven Arke Lang; Tom Florian Ulmer; Ulf Peter Neumann; Lara Rosaline Heij Journal: Cancers (Basel) Date: 2022-04-29 Impact factor: 6.575
Authors: Franziska Alexandra Meister; Georg Lurje; Suekran Verhoeven; Georg Wiltberger; Lara Heij; Wen-Jia Liu; Decan Jiang; Philipp Bruners; Sven Arke Lang; Tom Florian Ulmer; Ulf Peter Neumann; Jan Bednarsch; Zoltan Czigany Journal: Cancers (Basel) Date: 2022-01-30 Impact factor: 6.639
Authors: Jan Bednarsch; Zoltan Czigany; Lara R Heij; Iakovos Amygdalos; Daniel Heise; Philip Bruners; Tom F Ulmer; Ulf P Neumann; Sven A Lang Journal: Langenbecks Arch Surg Date: 2022-05-23 Impact factor: 2.895
Authors: Lea Penzkofer; Jens Mittler; Stefan Heinrich; Nicolas Wachter; Beate K Straub; Roman Kloeckner; Fabian Stoehr; Simon Johannes Gairing; Fabian Bartsch; Hauke Lang Journal: J Clin Med Date: 2022-09-30 Impact factor: 4.964